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Successful Sequential Liver-Kidney Transplantation in a 
Patient With Preformed Lymphocytotoxic Antibodies 
J. Fung, M. Griffin, R. Duquesnoy, B. Shaw, and T. Starzl 
SENSITIZATION of potential transplant 
recipients by formation of Iymphocyto-
toxic antibodies can be a result of prior blood 
transfusions, pregnancy, or failed allograft 
transplantation. While the presence of pre-
formed anti-HLA-A and -B Iymphocytotoxic 
antibodies does not appear to influence the 
survival of liver allografts, 1 this has been a 
contraindication in renal transplantation be-
cause of the high incidence of hyperacute 
rejection. 2 
We report a case of successful transplanta-
tion of a renal allograft, in the face of a 
positive warm T cell crossmatch sequentially 
following a prior hepatic allograft transplan-
tation from the same donor. 
MATERIALS AND METHODS 
Patient 
A GJPJAo, 43-year-old white female, with the diagnosis 
of primary biliary cirrhosis and renal failure due to 
interstitial nephritis, presented for combined liver-kidney 
transplantation. Preoperatively. serum BUN was 42 mg/ 
dL, serum creatinine (Cr) of 3.6 mg/dL, with a Cr 
clearance of 22 cc/min. Liver and renal allografts were 
harvested from a single donor and transplanted in a 
standard mannerJ.4 with baseline cyclosporine and ste-
roids, placing the liver and then the kidney allografts. 
Allograft function was monitored by biochemical and 
radiologic studies. 
Histocompatibility Studies 
These studies consisted of determination of the percent 
panel reactive antibodies (PRA), and donor Iymphocyto-
toxic crossmatches using serum samples obtained as 
follows: (I) pretransplant (PRE-OT /KT), (2) post liver, 
prekidney transplant (POST-OT /PRE-KT), and (3) 
posttransplantation (POST-OT jKT). Donor Iymphocy-
totoxic crossmatches (DLC) were done using a standard 
modified Amos Technique. 
lmmunoabsorptions 
Immunoabsorptions of test samples were done on 
pooled human platelets at a I: I dilution for 60 minutes x 
2, while absorptions of mouse antibodies were done on 
solid phase anti mouse antibody beads at a 2: I dilution. 
RESULTS 
Posttransplant Course 
Following completion of both the liver and 
kidney transplant, immediate function of both 
grafts was noted. Posttransplant evaluations 
of renal function by both renal ultrasound and 
radionuclide flow scans indicated normal 
function, and that the allograft was largely 
responsible for urinary excretory function. 
Posttransplant liver function tests demon-
strated a similar fall in both total bilirubin 
(TBIL) and transaminase levels. However, 
nine days following transplantation, elevation 
ofTBIL and biopsy-proven rejection occurred 
in the hepatic allograft, with normal kidney 
function. An II-day course of OKT3 5 was 
used to reverse the hepatic rejection. Follow-
up of 15 months revealed normal renal and he-
patic function without further episodes of 
rejection. 
H LA Evaluation 
PRE-OT /KT sample was strongly positive 
(1 :64 dilution) in DLC assays. Eight hours 
following completion of the liver transplant, 
the POST-OT /PRE-KT sample was negative 
by standard crossmatch techniques. 
POST-OT /KT samples were analyzed for 
reappearance of DLC. All samples remained 
negative for DLC until day 9 posttransplant, 
when OKT3 was started. This monoclonal 
,murine antibody has been shown to bind 
complement. As shown in Fig 1, PRA in 
nonabsorbed POST-OT /KT, also increased 
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Fig 1. Percent panel reactive antibody (%PRA) is 
expressed as a function of time following sequential 
liver-kidney transplantation. OKT3. given (intravenous-
ly) IV. was started on day 9. and finished on day 20. 
Open triangular points reflect %PRA prior to absorption 
on a sc,lid phase antimouse IgG immunoabsorbent. 
Closed circles are the corresponding %PRA values fol-
lowing immunoabsorption. 
during the period of OKT3 therapy. This 
artifactual rise in DLC and PRA during the 
period of OKT3 therapy was shown by 
absorption of POST -OT /KT samples on anti-
mouse antibody solid phase beads. Following 
absorptions, a fall in the % PRA to near levels 
found prior to and following OKT3 therapy 
was noted (Fig I). Similarly this absorption 
removed DLC in the same period. 
Immunogenetic analysis of the antibody 
population present in PRE-OT jKT and 
absent in POST-OT /KT samples revealed a 
HLA-B-35-associated specificity. This was 
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confirmed by elimination of DLC and PRA in 
PRE-OT /KT samples. 
DISCUSSION 
The mechanism by which the liver is pro-
tected from preformed antibody states in 
transplantation is not known. I It has not been 
clarified whether this reflects the unique 
architecture of the liver, the distribution of 
HLA antigens within the liver, or the possibil:" 
ity that the liver is able to "neutralize" spe-
cific antibodies by release of soluble HLA 
antigens. Starzl and coworkers first demon-
strated that sequential liver-kidney trans-
plants in presensitized dogs could protect the 
renal limb from acute rejection.6 This has 
been subsequently confirmed in the murine 
mode!.7 
The current study demonstrates the ability 
of sequential liver-kidney transplantation in 
the prevention of hyperacute renal rejection in 
a patient with demonstrated preformed 
anti-HLA lymphocytotoxic antibodies. The 
dramatic and sustained fall of DLC was tem-
porally related to placement of the liver allo-
graft. This was most likely due to absorption 
or neutralization of antibodies by the donor 
liver, and not by dilutional effects. 
The applicability of the concept of multior-
gan transplantation in transplanting potential 
presensitized renal transplant candidates is, of 
course, limited, but the mechanisms of protec-
tion using this model, if defined, may provide 
clues for less drastic therapeutic approaches. 
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